Meropenem
CAS No. 96036-03-2
Meropenem( ICI 194660 | Merrem I.V. | SM-7338 )
Catalog No. M16855 CAS No. 96036-03-2
Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 73 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMeropenem
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.
-
DescriptionMeropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. (In Vitro):Meropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.(In Vivo):Meropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection.
-
In VitroMeropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.
-
In VivoMeropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection. Animal Model:Male Sprague-Dawley rats (250-350 g) induced acute necrotizing pancreatitis Dosage:60 mg/kg Administration:Intraperitoneal injection; once Result:Significantly reduced the incidence of pancreatic infection.
-
SynonymsICI 194660 | Merrem I.V. | SM-7338
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
Recptorβ-Lactamase| D-alanyl-D-alanine carboxypeptidase DacB
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number96036-03-2
-
Formula Weight383.46
-
Molecular FormulaC17H25N3O5S
-
Purity>98% (HPLC)
-
SolubilityWater: 8 mg/mL (20.86 mM); DMSO: 77 mg/mL (200.8 mM)
-
SMILESO=C(C(N12)=C(S[C@@H]3CN[C@H](C(N(C)C)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O
-
Chemical Name(4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Edwards JR, et al. J Antimicrob Chemother, 1995, 36 Suppl A, 1-17.
molnova catalog
related products
-
5-Hydroxyuridine
5-Hydroxyuridine (OHUrd) is a purine nucleoside analogue with potential antitumor activity, demonstrating cytotoxicity against human colon adenocarcinoma cell lines.
-
Moxipraquine
Moxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs.
-
Chitin synthase inhi...
Chitin synthase inhibitor 4 is a chitin synthase (CHS) inhibitor with antimicrobial activity.Chitin synthase inhibitor 4 is a CHS-based compound and a candidate fungicide.
Cart
sales@molnova.com